New FDA Draft Guidance Part 11 Compliance
This webinar describe, As part of the Case for Quality program US FDA noted how an excessive focus by the industry on compliance rather than quality may be diverting resources and management attention toward meeting regulatory compliance requirements vs. adopting best quality practices.
1. There has also been a lower-than-anticipated investment in automation and digital technologies, which could greatly improve quality and process control.2. A key element is a risk-based, product quality, and patient-centric approach to Computer System Assurance (CSA) vs. the traditional Computer System Validation (CSV) Waterfall approach. 3. This encourages critical thinking based on product and process knowledge and quality risk management over prescriptive documentation-driven approaches.
This is where FDA determines “WHAT” is required and the “HOW” to accomplish this can occur in different ways.4 Does not have to be performed according to the “checklist” mindset of most CSV work,
- Where you crank out documents without specifically addressing the risk of potential failure of each requirement.
- GAMP5 supports the use of incremental, iterative, and evolutionary approaches including Agile, for the development of custom applications.
5.Keys to success include a robust Quality Management System and well-trained and highly disciplined teams following well-defined processes supported by tools and automation.
Webinar
Jan 01 2026, Thursday
01:00 PM EDT
90
Minutes
Intermediate Level
Code: GRC0000219